This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Conclusions

Authoring team

The conclusions of the trial are:

  • hypertension is a strong risk factor for the development of type II diabetes mellitus

  • only beta-blockers among the commonly used anti-hypertensive medications are associated with an increased risk of developing type II diabetes mellitus

  • when deciding whether to give a beta-blocker the increased risk of developing type II diabetes should be weighed against the proven cardiovascular benefits of beta-blockade

  • concerns about diabetes should not discourage the prescription of thiazide diuretics

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.